Search results for " OSTEOPOROSI"

showing 10 items of 110 documents

MRI of transient osteoporosis of the hip.

1991

Among the available imaging techniques such as conventional radiography, radionuclide bone scan, and computed tomography (CT), magnetic resonance imaging (MRI) has made significant contributions to the diagnosis of acute hip joint disease in adults by enabling early differentiation between such conditions as idiopathic avascular femoral head necrosis, septic coxitis, degenerative disease, and tumors. In this study we investigated the use of MRI for evaluation of patients with transient osteoporosis (TO). MRI with T1- and T2-weighted sequences in coronal, transverse, and sagittal sections was performed in 12 patients with retrospectively confirmed TO, both at the onset of the disease and lat…

musculoskeletal diseasesMalemedicine.medical_specialtyBone densityRadiographyOsteoporosisFemoral headmedicineHumansOrthopedics and Sports Medicinemedicine.diagnostic_testbusiness.industryMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingRadiographymedicine.anatomical_structureCoronal planeOrthopedic surgeryTransient osteoporosisOsteoporosisSurgeryFemaleHip JointRadiologybusinessArchives of orthopaedic and trauma surgery
researchProduct

Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.

2004

Today, androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, although it presents important complications such as osteoporosis. Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation. Introduction: Androgen-deprivation therapy (ADT) is a cornerstone of treatment for advanced prostate cancer. This therapy has iatrogenic complications, such as osteoporosis. The aim of our study was to evaluate the efficacy of neridronate, a relatively new bisphosphonate, to prevent bone loss during androgen ablation. Materials and Methods: Forty-eight osteoporotic patients with prostate cancer, tre…

musculoskeletal diseasesMalemedicine.medical_specialtyDeoxypyridinolineTime FactorsBicalutamideAntineoplastic Agents HormonalEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisUrologyBone and BonesAndrogen deprivation therapychemistry.chemical_compoundProstate cancerAbsorptiometry PhotonBone DensityMedicineNeridronic acidHumansOrthopedics and Sports MedicineAmino AcidsAgedCholecalciferolTriptorelin PamoateDiphosphonatesbusiness.industryProstatic NeoplasmsAndrogen AntagonistsBisphosphonatemedicine.diseaseAlkaline PhosphataseAndrogen deprivation therapy; Bisphosphonates; Neridronate; Osteoporosis; Prostate cancer; Absorptiometry Photon; Aged; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Androgens; Antineoplastic Agents Hormonal; Bone Density; Bone and Bones; Calcium; Cholecalciferol; Diphosphonates; Humans; Male; Osteoporosis; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate; SurgerySurgerychemistryAndrogensOsteoporosisCalciumbusinessCholecalciferolmedicine.drugJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
researchProduct

Zur Diagnostik der transitorischen Osteoporose der Hüfte und deren Darstellbarkeit in der MR-Tomographie

2008

Magnetic resonance (MR) imaging may distinguish transient osteoporosis of the hip from more severe hip diseases. 12 patients with transient osteoporosis of the hip underwent MR imaging. The initial and follow-up studies included T1- and T2-weighted images in coronal, transverse or sagittal planes. There were revealed 3 stages: diffuse-, focal-, and residual stage. This syndrome is characterized by hip pain, limping, and osteoporosis of the femoral head with preservation of the joint space. The clinical symptoms and abnormalities on MR images disappeared completely within 6-10 months.

musculoskeletal diseasesmedicine.diagnostic_testBone diseasebusiness.industryOsteoporosisMagnetic resonance imagingScintigraphymedicine.diseaseSagittal planeFemoral headmedicine.anatomical_structureCoronal planeMedicineTransient osteoporosisOrthopedics and Sports MedicineSurgerybusinessNuclear medicineZeitschrift für Orthopädie und ihre Grenzgebiete
researchProduct

Onset of MRONJ in Breast Cancer Patients after Switching from Low to High Dose of Bone Modifying Agents Due to Bone Metastases Development: A Single …

2022

Background: Medication-Related Osteonecrosis of the Jaw (MRONJ) is an adverse drug reaction mainly associated to bone modifying agents (BMAs). Breast cancer (BC) is the most frequent cancer worldwide. Its therapy can cause cancer treatment-induced bone loss (CTIBL), commonly treated with BMAs. The aims of this retrospective study are: to describe characteristics of BC patients under BMAs for CTIBL; to record any switch to high-dose BMAs; to assess MRONJ onset and to identify any factors associated with it. Patients: Authors included patients referred for MRONJ prevention to the Unit of Oral Medicine (University Hospital of Palermo). Results: Fourteen female BC patients under low-dose BMAs f…

osteonecrosis of the jawbisphosphonatebreast cancerBPosteonecrosis of the jaw; MRONJ; cancer treatment-induced bone loss; CTIBL; breast cancer; osteoporosis; bone metastases; bisphosphonates; BPs; denosumabcancer treatment-induced bone loosteoporosidenosumabPharmacology (medical)MRONJCTIBLbone metastaseOral; Volume 2; Issue 4; Pages: 274-285
researchProduct

MALATTIA OSSEA DI PAGET

2010

paget osteoporosis rimodellamento osseoSettore MED/09 - Medicina Interna
researchProduct

Valutazioni cliniche e bioumorali dopo 24 mesi di terapia con denosumab

2015

riabilitazione anticorpo monoclonale osteoporosiSettore MED/34 - Medicina Fisica E Riabilitativa
researchProduct

Il trattamento riabilitativo integrato alla terapia farmacologica con anticorpo anti RANK-L

2015

riabilitazione osteoporosi anticorpo monoclonaleSettore MED/34 - Medicina Fisica E Riabilitativa
researchProduct

Teriparatide (1-34) vs. parathyroid hormone (1-84) in women with severe postmenopausal osteoporosis: a randomized, head-to-head study.

2009

teriparatide parathyroid hormone osteoporosis menopauseSettore MED/09 - Medicina Interna
researchProduct

Role of hypogonadism in development of bone alterations in thalassemic patients

2005

Although transfusions and chelation therapy have improved survival of patients afflicted with Thalassemia Major (TM), endocrine alterations are still common complications. Particularly, hypogonadism plays an important role in the aetiology of osteoporosis in these patients. It is clear that in most patients the gonadal failure is a consequence of a pituitary damage and that a hypogonadotropic hypogonadism occurs; nevertheless, also a gonadal damage because of iron deposition may be a further cause of hypogonadism. Prevalence of the pubertal failure ranges between 50 to 80% of the cases. In some studies ferritin levels have been correlated with hypogonadism, suggesting that improvement of ch…

thalassemia hypogonadism osteoporosis iron overl
researchProduct

Multifactorial Assessment of Risk of Falling in 753 Post-Menopausal Women: A Multicenter Cross-Sectional Study by the Italian Group for the Study of …

2020

Giovanni Iolascon,1 Alessandro de Sire,1– 3 Dario Calafiore,1,4 Maria Grazia Benedetti,5 Carlo Cisari,2,6 Giulia Letizia Mauro,7 Silvia Migliaccio,8 Ranuccio Nuti,9 Giuseppina Resmini,10 Stefano Gonnelli,9 Antimo Moretti1 1Department of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, Naples, Italy; 2Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont “A. Avogadro”, Novara, Italy; 3Rehabilitation Unit, “Mons L. Novarese” Hospital, Vercelli, Moncrivello, Italy; 4Section of Neuromotor Rehabilitation, Department of Neuroscience, ASST Ca…

walking speed.medicine.medical_specialtyCross-sectional studymedicine.medical_treatmentOsteoporosiswalking speedboneaccidental falls osteoporosis walking speed fractures bone rehabilitationBone remodelingrehabilitationFractures Bone03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineVitamin D and neurologyHumansMedicineosteoporosi030212 general & internal medicineVitamin DAgedOriginal ResearchAged 80 and overRehabilitationaccidental fallbusiness.industryRC952-954.6General Medicinefracturesmedicine.diseaseosteoporosisPostmenopausePreferred walking speedCross-Sectional StudiesItalyGeriatricsfractureClinical Interventions in AgingCohortrehabilitation.Population studyFemaleaccidental fallsGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryClinical Interventions in Aging
researchProduct